Document is current
Any future updates will be listed below
-
Authors
Laprie, Anne https://orcid.org/0000-0002-0103-7935
Ken, Soléakhéna
Filleron, Thomas
Lubrano, Vincent
Vieillevigne, Laure
Tensaouti, Fatima
Catalaa, Isabelle
Boetto, Sergio
Khalifa, Jonathan
Attal, Justine
Peyraga, Guillaume
Gomez-Roca, Carlos
Uro-Coste, Emmanuelle
Noel, Georges
Truc, Gilles
Sunyach, Marie-Pierre
Magné, Nicolas
Charissoux, Marie
Supiot, Stéphane
Bernier, Valérie
Mounier, Muriel
Poublanc, Muriel
Fabre, Amandine
Delord, Jean-Pierre
Cohen-Jonathan Moyal, Elizabeth
-
Funding
Funding for this research was provided by:
Institut National Du Cancer (PHRC 2008)
- License Information
-
More Information
Article History
Received: 19 May 2018
Accepted: 24 January 2019
First Online: 21 February 2019
Ethics approval and consent to participate
: This trial was reviewed and approved by the French ethics committee on 28 April 2010: registration number 2009-A00594–53.This covers all participating centers.which are:Institut Claudius Regaud at Institut Universitaire du Cancer de Toulouse-Oncopole- Toulouse-France.Centre Paul Strauss- Strasbourg- France.Centre Georges-François Leclerc – Dijon- France.Centre Léon Bérard- Lyon- France.Institut de Cancérologie de la Loire- Saint-Priest en Jarez.Centre Val d’aurelle – Montpellier- France.Clinique Claude Bernard- Albi- France.All subjects signed a written informed consent form.
: Consent for publication is not applicable to this article.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
